12 digital health companies get a huge shout-out from Apple in new ad

Featured Story

12 digital health companies get a huge shout-out from Apple in new ad

June 20, 2014 1:42 pm by | 1 Comments

As I watched the new “Strength” ad for the iPhone 5s, all the devices looked like Apple accessories. Then I wondered how much the digital health companies had to pay…


Ties between industry & academia deepen as 7 pharmas offer ‘deprioritized’ drugs for research

Ties between industry & academia deepen as 7 pharmas offer ‘deprioritized’ drugs for research

July 22, 2014 2:22 pm by | 0 Comments

LONDON (Reuters) – A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening…


DePuy Mitek’s new sports medicine products target knee pain, platelet rich plasma production

DePuy Mitek’s new sports medicine products target knee pain, platelet rich plasma production

July 14, 2014 12:54 pm by | 0 Comments

Mitek Sports Medicine, a company involved in orthopaedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, has launched its MONOVISC High Molecular Weight Hyaluronan,…



FDA investigating uterine fibroids procedure tied to spread of rare cancer

FDA investigating uterine fibroids procedure tied to spread of rare cancer

July 8, 2014 1:59 pm by | 0 Comments

(Reuters) – A uterine surgical technique that has been linked with the spread of a rare type of cancer poses a serious concern to regulators that will be addressed this…


J&J closes $4B sale of Ortho-Clinical Diagnostics business to Carlyle Group

J&J closes $4B sale of Ortho-Clinical Diagnostics business to Carlyle Group

July 1, 2014 8:00 am by | 0 Comments

US Johnson & Johnson (NYSE:JNJ), or J&J, said yesterday it had closed the sale of its unit Ortho-Clinical Diagnostics to asset management firm The Carlyle Group LP (NASDAQ:CG) for some…


J&J Innovation, Janssen partner with Dana-Farber on lung cancer immunotherapies

J&J Innovation, Janssen partner with Dana-Farber on lung cancer immunotherapies

June 25, 2014 7:00 am by | 0 Comments

Johnson & Johnson Innovation LLC and Janssen Biotech Inc, both part of US Johnson & Johnson (NYSE:JNJ), said Tuesday they had entered into a three-year partnership with Dana- Farber Cancer…


J&J early stage collaborations span 3D printing for orthopedics, brown fat, biosensors

J&J early stage collaborations span 3D printing for orthopedics, brown fat, biosensors

June 19, 2014 10:59 am by | 0 Comments

A little over a year after it opened a Boston innovation center, Johnson & Johnson (NYSE: JNJ) unveiled a series of research and development collaborations and investments in early-stage companies…


Rodin Therapeutics brings in $12.9M for an epigenetics approach to treating brain disorders

Rodin Therapeutics brings in $12.9M for an epigenetics approach to treating brain disorders

June 2, 2014 9:10 am by | 0 Comments

Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, has completed USD12.9m Series A financing round, it was reported on Friday. The financing round…



New leukemia treatment from Pharmacyclics and J&J shown to improve survival

New leukemia treatment from Pharmacyclics and J&J shown to improve survival

May 31, 2014 7:39 am by | 0 Comments

CHICAGO (Reuters) – A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.
Ibrutinib, sold by Pharmac…


J&J plans to refresh medical device, diagnostics division with 30+ approval applications by ’17

J&J plans to refresh medical device, diagnostics division with 30+ approval applications by ’17

May 22, 2014 12:03 pm by | 0 Comments

(Reuters) – Johnson & Johnson said on Thursday it planned to file for approvals of more than 30 major products by the end of 2016 as the diversified healthcare company…


J&J’s prostate cancer treatment Zytiga not cost-effect before chemo, UK agency says

J&J’s prostate cancer treatment Zytiga not cost-effect before chemo, UK agency says

May 13, 2014 10:27 pm by | 0 Comments

LONDON (Reuters) – Britain’s healthcare cost-effectiveness agency NICE said on Wednesday that a Johnson & Johnson prostate cancer drug, originally invented in Britain, was not worth giving to patients who…


JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

April 10, 2014 5:26 pm by | 0 Comments

An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs to treat, and even potentially cure, patients with hepatitis B. Assembly Pharmaceuticals received an undisclosed…


To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

April 8, 2014 7:00 am by | 1 Comments

Big Pharma spends billions of dollars each year researching, developing and testing new treatments for cancer. In the meantime, it’s also collecting millions of data points that figuratively sit on…


Limitations imposed on use of FDA warning letters

Limitations imposed on use of FDA warning letters

March 25, 2014 10:41 pm by | 0 Comments

By Anne K. Walsh – The Supreme Court of Arkansas recently overturned (here and here) a lower court’s $1.2 billion award to the State of Arkansas, and also reversed and…


J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment

J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment

March 10, 2014 12:54 pm by | 0 Comments

In another move to potentially beef up its Alzheimer’s pipeline, Johnson & Johnson has struck a drug development deal with one of the companies located at its innovation lab in…


J&J and Pharmacyclics’ new chronic lymphocytic leukemia drug approved

J&J and Pharmacyclics’ new chronic lymphocytic leukemia drug approved

February 12, 2014 1:20 pm by | 0 Comments

(Reuters) – U.S. health regulators on Wednesday approved the Johnson & Johnson and Pharmacyclics Inc cancer drug Imbruvica to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer….